Phase 4 Long COVID Trial, Recruiting (NCT06792214)

Phase 4 Long COVID Trial, Recruiting NCT06792214 Sponsor: Mount Sinai Hospital, Canada Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT06792214 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older
People who have tested positive for COVID-19 using a PCR test within 5 days of being admitted to hospital
People who are breathing normally without the help of extra oxygen
People who are able to sign a consent form themselves, or who have someone legally authorised to make decisions on their behalf

Who may not be able to join:

People who have a serious allergy (such as anaphylaxis) to Paxlovid or Veklury, or who are taking certain medications that interact with these drugs in ways that could be harmful (confirm with trial site for specific medications)
People who have taken Paxlovid or Veklury in the 14 days before joining the trial
People who are currently receiving extra oxygen to help them breathe
People who had a positive COVID-19 PCR or rapid antigen test result between 5 and 90 days before being admitted to hospital
People who are estimated to have 3 months or less to live
People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 416-843-8403

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06792214

Sponsor: Mount Sinai Hospital, Canada

Phase: Phase 4

Status: Recruiting

Condition: Long COVID

Trial contact: 416-843-8403

More information: https://clinicaltrials.gov/study/NCT06792214

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older
People who have tested positive for COVID-19 using a PCR test within 5 days of being admitted to hospital
People who are breathing normally without the help of extra oxygen
People who are able to sign a consent form themselves, or who have someone legally authorised to make decisions on their behalf

Who may not be able to join:

People who have a serious allergy (such as anaphylaxis) to Paxlovid or Veklury, or who are taking certain medications that interact with these drugs in ways that could be harmful (confirm with trial site for specific medications)
People who have taken Paxlovid or Veklury in the 14 days before joining the trial
People who are currently receiving extra oxygen to help them breathe
People who had a positive COVID-19 PCR or rapid antigen test result between 5 and 90 days before being admitted to hospital
People who are estimated to have 3 months or less to live
People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Mount Sinai Hospital, Canada

Registry

ClinicalTrials.gov

Start date

3 January 2025

Est. completion

1 January 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Recruitment rate; Post-acute sequelae of COVID-19 (PASC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov